Drugs / ROTAVIN
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01375907 | Aug → Oct 2009 | diarrheal disease | National Institute of Hygiene and Epidemiology, Vietnam | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03703336 | Mar 2019 → Jan 2020 | Rotavirus infection, diarrheal disease | Center for Research and Production of Vaccines and Biologicals, Vietnam | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotavin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01375907 ↗ |
| Modality | Vaccine | “We tested a candidate live, oral, rotavirus vaccine (Rotavin-M1™) derived from an attenuated G1P [8] strain (KH0118-2003) isolated from a child in Vietnam.” PMID 22520120 ↗ Apr 2012 |
| Route | Oral | “We tested a candidate live, oral, rotavirus vaccine (Rotavin-M1™) derived from an attenuated G1P [8] strain (KH0118-2003) isolated from a child in Vietnam.” PMID 22520120 ↗ Apr 2012 |